Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Financial Flexibility Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Financial Flexibility Index of -0.01x as of June 2023. Free cash flow of €-43.91 Million (operating CF €-64.53 Million minus capex €20.62 Million) represents 0% of total liabilities (€3.97 Billion). Check Tianjin Zhong Xin Pharmaceutical Group C total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 13 annual periods. For the full cash flow conversion analysis, see 2TZ cash flow metrics.
Annual Financial Flexibility Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year free cash flow to debt coverage for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. Explore Tianjin Zhong Xin Pharmaceutical Group C (2TZ) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | €579.68 Million | €461.07 Million | €4.59 Billion | ▼ -64.6% |
| 2024 | 0.36x | €1.04 Billion | €924.67 Million | €2.92 Billion | ▲ +54.4% |
| 2023 | 0.23x | €829.42 Million | €688.49 Million | €3.58 Billion | ▲ +6.2% |
| 2022 | 0.22x | €785.15 Million | €677.25 Million | €3.61 Billion | ▼ -44.9% |
| 2021 | 0.40x | €1.01 Billion | €852.40 Million | €2.55 Billion | ▲ +7.2% |
| 2020 | 0.37x | €860.58 Million | €671.42 Million | €2.33 Billion | ▲ +22.0% |
| 2019 | 0.30x | €701.10 Million | €495.49 Million | €2.32 Billion | ▲ +17.8% |
| 2018 | 0.26x | €525.95 Million | €350.14 Million | €2.05 Billion | ▲ +363.5% |
| 2017 | 0.06x | €110.45 Million | €-3.97 Million | €2.00 Billion | ▼ -78.7% |
| 2016 | 0.26x | €533.98 Million | €417.77 Million | €2.06 Billion | ▲ +12.4% |
| 2015 | 0.23x | €453.22 Million | €360.58 Million | €1.96 Billion | ▲ +61.0% |
| 2014 | 0.14x | €357.01 Million | €286.85 Million | €2.49 Billion | ▲ +34.8% |
| 2013 | 0.11x | €285.86 Million | €213.44 Million | €2.69 Billion | — |